Literature DB >> 29305112

Design and intestinal mucus penetration mechanism of core-shell nanocomplex.

Xin Zhang1, Hongbo Cheng1, Wei Dong1, Meixia Zhang2, Qiaoyu Liu1, Xiuhua Wang1, Jian Guan1, Haiyang Wu1, Shirui Mao3.   

Abstract

The objective of this study was to design intestinal mucus-penetrating core-shell nanocomplex by functionally mimicking the surface of virus, which can be used as the carrier for peroral delivery of macromolecules, and further understand the influence of nanocomplex surface properties on the mucosal permeation capacity. Taking insulin as a model drug, the core was formed by the self-assembly among positively charged chitosan, insulin and negatively charged sodium tripolyphosphate, different types of alginates were used as the shell forming material. The nanocomplex was characterized by dynamic light scattering (DLS), atomic force microscopy (AFM) and FTIR. Nanocomplex movement in mucus was recorded using multiple particle tracking (MPT) method. Permeation and uptake of different nanocomplex were studied in rat intestine. It was demonstrated that alginate coating layer was successfully formed on the core and the core-shell nanocomplex showed a good physical stability and improved enzymatic degradation protection. The mucus penetration and MPT study showed that the mucus penetration capacity of the nanocomplex was surface charge and coating polymer structure dependent, nanocomplex with negative alginate coating had 1.6-2.5 times higher mucus penetration ability than that of positively charged chitosan-insulin nanocomplex. Moreover, the mucus penetration ability of the core-shell nanocomplex was alginate structure dependent, whereas alginate with lower G content and lower molecular weight showed the best permeation enhancing ability. The improvement of intestine permeation and intestinal villi uptake of the core-shell nanocomplex were further confirmed in rat intestine and multiple uptake mechanisms were involved in the transport process. In conclusion, core-shell nanocomplex composed of oppositely charged materials could provide a strategy to overcome the mucus barrier and enhance the mucosal permeability.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alginate; Chitosan; Core-shell nanocomplex; Mucus-penetrating; Permeability

Mesh:

Substances:

Year:  2018        PMID: 29305112     DOI: 10.1016/j.jconrel.2017.12.034

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Ionic Liquids: Promising Approach for Oral Drug Delivery.

Authors:  Linxia Jiang; Yi Sun; An Lu; Xiangyu Wang; Yujie Shi
Journal:  Pharm Res       Date:  2022-04-21       Impact factor: 4.580

Review 2.  Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins.

Authors:  Ying Han; Zhonggao Gao; Liqing Chen; Lin Kang; Wei Huang; Mingji Jin; Qiming Wang; You Han Bae
Journal:  Acta Pharm Sin B       Date:  2019-01-10       Impact factor: 11.413

3.  Modulating intestinal mucus barrier for nanoparticles penetration by surfactants.

Authors:  Xin Zhang; Wei Dong; Hongbo Cheng; Meixia Zhang; Yongqiang Kou; Jian Guan; Qiaoyu Liu; Mingyue Gao; Xiuhua Wang; Shirui Mao
Journal:  Asian J Pharm Sci       Date:  2018-10-12       Impact factor: 6.598

Review 4.  Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges.

Authors:  Shangyong Li; Hui Zhang; Kaiwei Chen; Mengfei Jin; Son Hai Vu; Samil Jung; Ningning He; Zhou Zheng; Myeong-Sok Lee
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 5.  Chitosan-Based Nanomaterials for Drug Delivery.

Authors:  Jianghua Li; Chao Cai; Jiarui Li; Jun Li; Jia Li; Tiantian Sun; Lihao Wang; Haotian Wu; Guangli Yu
Journal:  Molecules       Date:  2018-10-16       Impact factor: 4.411

6.  Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment.

Authors:  Xiaoman Mao; Shuang Wu; Pilar Calero-Pérez; Ana P Candiota; Paula Alfonso; Jordi Bruna; Victor J Yuste; Julia Lorenzo; Fernando Novio; Daniel Ruiz-Molina
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.